Using EHR in clinical studies
Search documents
National Cancer Institute Broadens Partnership with Medidata to Bring Unmatched Continuity of Medical and Clinical Data for Lead Protocol Organizations
Globenewswire· 2025-11-18 13:00
Core Insights - Medidata has launched the Medidata Data Experience, which includes Health Record Connect and Rave Companion, aimed at expediting the development of life-saving medicines for patients by integrating electronic health records (EHR) into clinical trials [1][2] Group 1: Medidata Data Experience - The Medidata Data Experience will be available to select National Cancer Institute (NCI) Lead Protocol Organizations (LPO), facilitating the automatic elevation of patient data from EHR systems into the Medidata Platform [1] - The integration of Health Record Connect and Rave Companion is expected to reduce administrative burdens, enhance insights, and allow clinical sites to focus more on patient care [1][2] Group 2: Benefits of the New Solutions - The new solutions aim to solve the industry's long-standing challenge of using EHR in clinical studies, enabling NCI LPOs to input data up to 90% faster [2] - By minimizing duplicative tasks for research sites, the technology is designed to accelerate timelines and improve overall data quality, enhancing the experience for both researchers and patients [2] Group 3: Medidata's Experience and Impact - Medidata has supported the NCI Cancer Therapy Evaluation Program (CTEP) for 17 years, reinforcing NCI's ability to manage clinical operations effectively [3] - The company has a strong track record, having powered over 36,000 trials and served 11 million patients, showcasing its expertise and extensive clinical trial data set [4]